The estimated Net Worth of Annette Heroux is at least $15.8 Thousand dollars as of 12 December 2003. Ms Heroux owns over 8,400 units of Icad Inc stock worth over $15,846 and over the last 21 years she sold ICAD stock worth over $0.
Ms has made over 2 trades of the Icad Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently she exercised 8,400 units of ICAD stock worth $6,804 on 12 December 2003.
The largest trade she's ever made was exercising 10,000 units of Icad Inc stock on 12 November 2003 worth over $8,100. On average, Ms trades about 4,600 units every 8 days since 2003. As of 12 December 2003 she still owns at least 11,400 units of Icad Inc stock.
You can see the complete history of Ms Heroux stock trades at the bottom of the page.
Annette L. Heroux is the VP of Admin. at Icad Inc.
Ms Heroux is 64, she's been the VP of Admin. of Icad Inc since . There are 2 older and 9 younger executives at Icad Inc. The oldest executive at Icad Inc is Michael S. Klein, 67, who is the Exec. Chairman & CEO.
Annette's mailing address filed with the SEC is 4 TOWNSEND WEST, SUITE 17, NASHUA, NH, 03063.
Over the last 22 years, insiders at Icad Inc have traded over $10,970,060 worth of Icad Inc stock and bought 704,596 units worth $1,672,448 . The most active insiders traders include Anthony F Ecock, Nathaniel Dalton, and Kevin C Burns. On average, Icad Inc executives and independent directors trade stock every 45 days with the average trade being worth of $39,056. The most recent stock trade was executed by Dana R Brown on 31 March 2023, trading 40,000 units of ICAD stock currently worth $52,000.
icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and computed tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com.
Icad Inc executives and other stock owners filed with the SEC include: